Poulton Stuart
Karyopharm Therapeutics Inc. · EVP
Poulton Stuart is listed in filings as EVP at Karyopharm Therapeutics Inc.. This profile follows SEC Form 4 activity through May 15, 2026, including sale activity. Recent filings connect the profile to Karyopharm Therapeutics Inc. (KPTI). The current snapshot covers public activity from Jul 31, 2024 to May 15, 2026. Reported amounts are shown as $3.8K to $3.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $48k5.1k shares | SellMar 2, 2026 | $9.41 | $9.51 | |
| $3.3k378 shares | SellFeb 17, 2026 | $8.63 | $9.51 | |
| $2.6k401 shares | SellSep 15, 2025 | $6.43 | $9.51 | |
| $835191 shares | SellJul 29, 2025 | $4.37 | $9.51 | |
| $3.7k5.9k shares | SellFeb 18, 2025 | $0.63 | $9.51 | |
| $3.1k2.9k shares | SellJul 30, 2024 | $1.06 | $9.51 |